Corporate News 09-Dec-22
USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out by them at the company's Oncology Injectable Formulation Facility at Panelav during the period from 4 October 2022 to 14 October 2022. This was pre-approval inspection to cover our Oncology Injectable drug products for which ANDAs were filed with USFDA. The Company had also started receiving ANDA approval manufactured at this facility.
Previous News
Alembic Pharmaceuticals receives USFDA approval for various products
( Corporate News - 09-May-24 09:01 )
Alembic Pharmaceuticals update on its Namthang facility in Sikkim
( Corporate News - 04-Oct-23 14:52 )
Alembic Pharmaceuticals reports consolidated net loss of Rs 65.88 crore in the June 2022 quarter
( Results - Announcements 04-Aug-22 17:27 )
Alembic Pharmaceuticals' derma unit at Karakhadi clears USFDA inspection
( Corporate News - 13-Mar-23 09:08 )
Alembic Pharma says USFDA clears Karakhadi facility
( Hot Pursuit - 13-Mar-23 09:35 )
Alembic Pharmaceuticals receives USFDA approval for Acitretin Capsules
( Corporate News - 07-Aug-24 18:11 )
Alembic Pharma gains after USFDA tentative nod for Acalabrutinib capsules
( Hot Pursuit - 19-Jan-23 14:12 )
Alembic Pharma suspends Sikkim facility operations due to floods
( Hot Pursuit - 04-Oct-23 14:39 )
Alembic Pharmaceuticals to acquire 40% stake in Aleor Dermaceuticals
( Corporate News - 29-Mar-22 15:41 )
Alembic Pharmaceuticals receives USFDA's tentative approval for Acalabrutinib Capsules
( Corporate News - 19-Jan-23 14:19 )
Alembic Pharma buys out Orbicular's stake in Aleor Dermaceuticals
( Hot Pursuit - 29-Mar-22 15:23 )
Other Stories
Tata Motors records 12% decline in Q2 sales
01-Oct-24 18:04
Tata Motors records 15% decline in September sales
01-Oct-24 17:55
Man Infra set to launch its highly anticipated Vile Parle project
01-Oct-24 17:48
Padam Cotton Yarns to declare Quarterly Result
01-Oct-24 17:39
Blueblood Ventures schedules board meeting
01-Oct-24 17:39
CRISIL to discuss results
01-Oct-24 17:39
Indian Renewable Energy Deve. Agency to convene board meeting
01-Oct-24 17:39
Ashapuri Gold Ornament schedules board meeting
01-Oct-24 17:38
Bijoy Hans to conduct board meeting
01-Oct-24 17:38
RS Software (India) to announce Quarterly Result
01-Oct-24 17:38
Back
Top
